LEONI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 164
EU - Europa 73
AS - Asia 51
OC - Oceania 2
Totale 290
Nazione #
US - Stati Uniti d'America 160
IT - Italia 38
HK - Hong Kong 21
GB - Regno Unito 16
JP - Giappone 10
AE - Emirati Arabi Uniti 5
IN - India 5
CA - Canada 4
DE - Germania 3
FR - Francia 3
SE - Svezia 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
DK - Danimarca 2
IL - Israele 2
IR - Iran 2
KR - Corea 2
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
MK - Macedonia 1
NL - Olanda 1
PH - Filippine 1
RO - Romania 1
Totale 290
Città #
Ashburn 20
Chicago 11
Boardman 9
New York 9
Buffalo 7
Birmingham 6
Council Bluffs 6
Seattle 6
Ancona 5
Osaka 5
Athens 4
Central 4
Centro 4
Dubai 4
London 4
Los Angeles 4
Arlington 3
Crugers 3
Henderson 3
Istanbul 3
Porto 3
Rome 3
Salem 3
San Francisco 3
Adelaide 2
Ajax 2
Brasschaat 2
Cardiff 2
Dallas 2
Denver 2
Gothenburg 2
Houston 2
Hyderabad 2
Las Vegas 2
Montreal 2
Paris 2
Perugia 2
Portland 2
Providence 2
Romano di Lombardia 2
Scottsdale 2
Seoul 2
Squinzano 2
Tokyo 2
Turin 2
Wanchai 2
Ariano Irpino 1
Arzignano 1
Assisi 1
Bacoli 1
Bitola 1
Caserta 1
Casoria 1
Catania 1
Chapel Hill 1
Cingoli 1
Copenhagen 1
Deva 1
Edison 1
Elk Grove Village 1
Frankfurt am Main 1
Glenview 1
Gurgaon 1
Herndon 1
Jersey City 1
Jerusalem 1
Kirkland 1
Kolkata 1
Kumamoto 1
Ledbury 1
Lincoln 1
Lombard 1
Macerata 1
Miami 1
Mérignac 1
Naples 1
Omaha 1
Pasadena 1
Pittsburgh 1
Presque Isle 1
Quartu Sant'Elena 1
Reston 1
Rochester 1
Rodriguez 1
Rottofreno 1
Salt Lake City 1
Sioux Falls 1
Stockholm 1
Tel Aviv 1
The Bronx 1
Tranbjerg 1
Trivandrum 1
Turbigo 1
Utsunomiya 1
Valladolid 1
Totale 225
Nome #
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells, file e18b8790-49c9-d302-e053-1705fe0a27c8 27
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol, file e18b878f-c85a-d302-e053-1705fe0a27c8 20
Acute megakaryoblastic leukemia: experience of GIMEMA trials, file e18b878f-d964-d302-e053-1705fe0a27c8 16
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry., file e18b878f-e0a3-d302-e053-1705fe0a27c8 16
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation, file e18b8790-4149-d302-e053-1705fe0a27c8 16
Human white adipocytes convert into “rainbow” adipocytes in vitro, file e18b8792-0b4c-d302-e053-1705fe0a27c8 14
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes., file e18b8790-49cc-d302-e053-1705fe0a27c8 13
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow, file e18b8790-47b2-d302-e053-1705fe0a27c8 12
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning., file e18b8790-47b5-d302-e053-1705fe0a27c8 12
Biosafety evidence for human dedifferentiated adipocytes, file e18b8790-4902-d302-e053-1705fe0a27c8 12
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome, file e18b8790-42ee-d302-e053-1705fe0a27c8 10
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma., file e18b878f-ffe1-d302-e053-1705fe0a27c8 9
Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen., file e18b8790-49fc-d302-e053-1705fe0a27c8 9
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate, file e18b8790-4c60-d302-e053-1705fe0a27c8 9
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma, file e18b878f-d6ab-d302-e053-1705fe0a27c8 7
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide., file e18b878f-e123-d302-e053-1705fe0a27c8 7
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients., file e18b8790-4b5e-d302-e053-1705fe0a27c8 7
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype, file e18b8790-ab06-d302-e053-1705fe0a27c8 7
Glial-like differentiation potential of human mature adipocytes, file e18b8790-4900-d302-e053-1705fe0a27c8 6
Molecular and functional characterization of human bone marrow adipocytes, file e18b8790-503d-d302-e053-1705fe0a27c8 6
Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations., file e18b878f-e122-d302-e053-1705fe0a27c8 5
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study, file e18b878f-c858-d302-e053-1705fe0a27c8 4
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease, file e18b878f-d173-d302-e053-1705fe0a27c8 4
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, file e18b878f-d555-d302-e053-1705fe0a27c8 4
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study., file e18b878f-dfe5-d302-e053-1705fe0a27c8 4
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study, file e18b8790-00f6-d302-e053-1705fe0a27c8 4
Imatinib for refractory chronic graft-versus-host disease with fibrotic features, file e18b8790-1d40-d302-e053-1705fe0a27c8 4
Valproic acid for the treatment of low-risk myelodisplastic syndromes: a case report and a review of literature, file e18b8790-43a8-d302-e053-1705fe0a27c8 4
Plasticity of human dedifferentiated adipocytes toward endothelial cells, file e18b8790-503b-d302-e053-1705fe0a27c8 4
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion, file e18b8790-47b7-d302-e053-1705fe0a27c8 3
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA., file e18b8790-4dcb-d302-e053-1705fe0a27c8 3
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment, file e18b8791-d488-d302-e053-1705fe0a27c8 3
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis., file e18b878f-cf13-d302-e053-1705fe0a27c8 2
Imatinib for refractory chronic graft-versus-host disease with fibrotic features, file e18b8790-1d41-d302-e053-1705fe0a27c8 2
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes, file e18b8790-4677-d302-e053-1705fe0a27c8 2
Partial deletion of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemi, file e18b878f-d965-d302-e053-1705fe0a27c8 1
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme, file e18b8790-1fcc-d302-e053-1705fe0a27c8 1
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype, file e18b8790-2dff-d302-e053-1705fe0a27c8 1
Totale 290
Categoria #
all - tutte 1.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 0 0 0 0 0 0 0 1 4
2022/2023276 35 23 16 40 40 19 25 52 18 6 2 0
2023/20243 3 0 0 0 0 0 0 0 0 0 0 0
Totale 290